June 3, 2026Journal of the American College of Cardiology1 citationsOpen Access
View Full PaperKidney and Survival Benefits of Semaglutide in Diabetes With Chronic Kidney Disease
Key Result
Semaglutide provides kidney and survival benefits for patients with type 2 diabetes and chronic kidney disease.
Key Points
- The aim is to evaluate the benefits of semaglutide in improving kidney outcomes and survival in individuals with diabetes and chronic kidney disease.
- Randomized trial design
- Intervention with semaglutide
- Focus on chronic kidney disease progression and mortality outcomes.
- Semaglutide treatment associated with a significant reduction in CKD progression (HR not specified) and improved survival rates (p-value not specified).
Main Result
Absolute Event Rate: 0% vs 0%
Abstract
Cardiovascular disease increases risks of chronic kidney disease (CKD) progression and mortality in type 2 diabetes.
Expert Takes9 quotes
1/9
“Taken together, the results from this analysis represent a key opportunity to intensify [cardiovascular] kidney therapies in real-world practice in high-risk CKD even without overt [cardiovascular disease] being present, given comparable event rates and benefits from therapies. Implementing thera...”
ACC Journal ScanView source